Concerned over incorporation of strict WHO, ICH guidelines in the proposed revision of Schedule M, the pharmaceutical industry in the country has urged the Union health ministry to revise the Schedule ...
BEIJING, May 24, 2013 -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that Sinovac Beijing, the main operating subsidiary company of Sinovac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results